v3.26.3
Stockholders’ Equity (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Stockholders’ Equity [Abstract]    
Schedule of Valuation Assumptions

The assumptions used for options granted during the six months ended June 30, 2026, are as follows:

 

   June 30, 2026 
Exercise Price   $6.00- $12.00 
Expected dividends   0%
Expected volatility   322.65% - 322.94%
Risk free interest rate   4.04% - 4.51%
Expected life of option   10 

The assumptions used for options granted during the year ended December 31, 2025 and 2024, are as follows:

 

   December 31,
2025
 
Exercise Price    $5.00 - $7.40 
Expected dividends    0%
Expected volatility    363.00% - 366.01%
Risk free interest rate    4.04% - 4.57%
Expected life of option    10 years 

 

   December 31,
2024
 
Exercise Price  $35.60 - $38.40 
Expected dividends   0%
Expected volatility   215.44% - 218.11%
Risk free interest rate   4.17% - 4.69%
Expected life of option   10 years 
Schedule of Warrant Activity

The following is a summary of the Company’s stock option activity:

 

   Options  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Life

(in years)

 
Balance – December 31, 2025 – outstanding   569,922   $36.05    9.06 
Granted   1,283,500    9.46    9.46 
Exercised   
-
    
    - 
Forfeited/Cancelled   
-
    
    - 
Expired   (51)   90,876    - 
Balance – June 30, 2026 – outstanding   1,853,371    15.13    9.31 
Balance – June 30, 2026 – exercisable   1,834,726   $14.67    9.31 

The following is a summary of the Company’s stock option activity:

 

   Options   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual Life
(in years)
 
Balance – December 31, 2024 – outstanding   103,679   $178.60    8.84 
Granted   466,243   $4.34    10.00 
Exercised   -    -    - 
Forfeited/Cancelled   -    -    - 
Balance – December 31, 2025 – outstanding   569,922   $36.05    9.06 
Balance – December 31, 2025 – exercisable   557,277   $34.96    9.04 
Schedule of Option Outstanding and Exercisable
Options Outstanding   Options Exercisable 

Weighted

Average

Exercise Price

  

Number

Outstanding

  

Weighted

Average

Remaining

Contractual

Life

(in years)

  

Weighted

Average

Exercise Price

  

Number

Exercisable

  

Weighted

Average

Remaining

Contractual

Life
(in years)

 
$15.13    1,853,371    9.31   $14.67    1,834,726    9.31 
Option Outstanding   Option Exercisable 
Weighted
Average
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life
(in years)
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
$36.05    569,922    9.06   $34.96    557,277    9.04 
Schedule of Warrant Activity

The assumptions used for warrants granted during the six months ended June 30, 2026, are as follows:

 

   June 30, 2026 
Exercise Price   $5.14 - $10.00 
Expected dividends   %
Expected volatility   322.86% - 323.02%
Risk free interest rate   3.78% - 4.25%
Expected life of warrants   1.81 - 4.39 years 

The assumptions used for warrants granted during the year ended December 31, 2025, are as follows:

 

   December 31,
2025
 
Exercise Price   $6.80 - 24.00 
Expected dividends   0%
Expected volatility   196.11% - 279.01%
Risk free interest rate   3.57% - 4.45%
Expected life of warrants   5 years 

 

   December 31,
2024
 
Exercise Price  $5.20 - 140.00 
Expected dividends   0%
Expected volatility   201.06% - 309.08%
Risk free interest rate   3.41% - 4.66%
Expected life of warrants   5 years 
Schedule of Warrant Activity

The following is a summary of the Company’s warrant activity: 

 

   Warrants  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Life

(in years)

 
Balance – December 31, 2025 – outstanding   2,401,378   $12.51    3.55 
Granted   67,292    10.00    5.00 
Exercised   (427,768)   
     
Forfeited/Cancelled   (102)   
     
Balance – June 30, 2026 – outstanding   2,040,800   $11.42    3.23 
Balance – June 30, 2026 – exercisable   2,040,800   $11.42    3.23 

The following is a summary of the Company’s warrant activity:

 

   Warrants   Weighted Average
Exercise Price
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Balance – December 31, 2024 – outstanding   1,310,343   $8.00    3.64 
Granted   1,183,367   $14.71    5.00 
Exercised   (92,043)  $5.14    - 
Forfeited/Cancelled   (290)  $2,363    - 
Balance – December 31, 2025 – outstanding   2,401,378   $6.73    3.55 
Balance – December 31, 2025 – exercisable   2,401,378   $6.73    3.55 
Schedule of Warrants Outstanding and Exercisable
Warrants Outstanding   Warrants Exercisable 

Weighted

Average

Exercise Price

  

Number

Outstanding

  

Weighted

Average

Remaining

Contractual

Life

(in years)

  

Weighted

Average

Exercise Price

  

Number

Exercisable

  

Weighted

Average

Remaining

Contractual

Life

(in years)

 
$11.42    2,040,800    3.23   $11.42    2,040,800    3.23 
 Warrants Outstanding    Warrants Exercisable 
 Weighted
Average
Exercise
Price
    Number
Outstanding
    Weighted
Average
Remaining
Contractual
Life
(in years)
    Weighted
Average
Exercise
Price
    Number
Exercisable
    Weighted
Average
Remaining
Contractual
Life
(in years)
 
$6.73    2,401,378    3.55   $6.73    2,401,378    3.55